Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA7 | P43166 | 1/20 | 0.31 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22663678 | 0.89 | ALDH1A1 (0.50) | KDM4EALDH1A1CYP3A4TSHRCA1 | |
| SCHEMBL18427578 | 0.89 | EPHX1 (0.35) | KDM4EALDH1A1CYP3A4TSHR | |
| SCHEMBL18923159 | 0.88 | — | — | |
| SCHEMBL10306197 | 0.88 | — | — | |
| SCHEMBL17952562 | 0.87 | KDM4E (0.38) | KDM4EALDH1A1TSHR | |
| SCHEMBL20858047 | 0.87 | CA12 (0.30) | ALDH1A1CA12CA1CA2CA7 | |
| SCHEMBL2179490 | 0.87 | LMNA (0.44) | ALDH1A1CYP3A4TSHR | |
| SCHEMBL20056438 | 0.87 | — | — | |
| SCHEMBL22857636 | 0.85 | LMNA (0.48) | ALDH1A1CYP3A4TSHR | |
| SCHEMBL21255235 | 0.85 | ALDH1A1 (0.37) | ALDH1A1CYP3A4TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180127443-A1 | Methods of Making Metal Halide Perovskites | FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. | 2018-05-10 | — | — | US | disclosed |
| US-9896462-B1 | Metal halide perovskites, methods, and devices | FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2018-02-20 | — | — | US | disclosed |
| US-20180037813-A1 | Organic-Inorganic Hybrid Perovskites, Devices, and Methods | FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. | 2018-02-08 | — | — | US | disclosed |
| US-8772301-B2 | Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof | SUNOVION PHARMACEUTICALS, INC. (US) | 2014-07-08 | — | — | US | disclosed |
| EP-1940401-B1 | ACYLATED SPIROPIPERIDINE DERIVATIVES AS MELANOCORTIN-4 RECEPTOR MODULATORS | MERCK SHARP & DOHME (US) | 2012-07-11 | — | — | EP | disclosed |
| EP-1935887-A1 | Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands | Aventis Pharmaceuticals, Inc. (US) | 2008-06-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180037813-A1 | Organic-Inorganic Hybrid Perovskites, Devices, and Methods | TYR, HCN4, BMI1 | KDM4E 2715/4885ALDH1A1 166/4885CYP3A4 1162/4885 |
| US-20180127443-A1 | Methods of Making Metal Halide Perovskites | SOD1, SLC6A12, HCN1 | KDM4E 1786/4885ALDH1A1 722/4885CYP3A4 3305/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.